News
(HealthDay News) — China has promised to give $500 million to the World Health Organization (WHO) over the next 5 years, positioning itself to become the group’s top donor, The Washington Post ...
Some pharmacists worry that tariffs could drive companies out of business while raising prices and creating more drug ...
Our large observational study adds long-term survival to the mounting data supporting the use and safety of conservative surgery for low-risk, early-stage cervical carcinoma,” the researchers wrote.
Children with ALL who were overweight or obese at 2 or more time points had an increased risk of relapse and death.
The results of our study suggest a concerning pattern in cancer center advertising, particularly among top-ranked institutions,” researchers wrote.
Cuts to Medicare reimbursement could prevent cancer patients from accessing care and force practices to downsize or close, radiation oncologists say.
President Donald Trump's claim that prescription drug prices will be reduced “almost immediately" under a new executive order is misleading.
The fact that this study showed a significant difference in its primary end point and the objective response rate suggests that FOLFIRINOX should be considered as a standard of care,” researchers ...
Most-favored-nation pricing is “founded on incorrect assumptions about where high out-of-pocket costs really come from and what it would mean for the US to adopt cost-effectiveness standards used by ...
We want you to take advantage of everything Cancer Therapy Advisor has to offer. To view unlimited content, log in or register for free.
Patients with prostate cancer may have a lower risk of recurrence if they take multivitamin supplements after diagnosis, new data suggest.
The HHS and FDA are encouraging stakeholders to submit their ideas for deregulatory actions in the next 60 days.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results